Vitamin E and cardiovascular disease

American Journal of Therapeutics

Volumn 17, Issue 3, 2010, Pages

  Saremi, Adonis ^a   Arora, Rohit ^a  

^a The Chicago Medical College   (United States)

Author keywords

Alpha tocopherol; Cardiovascular disease; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; MULTIVITAMIN; NITRIC OXIDE; OMEGA 3 FATTY ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACEBO; RAMIPRIL; UBIQUINONE;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CELL MOTILITY; CLINICAL TRIAL; CYTOTOXICITY; DRUG MEGADOSE; ENDOTHELIUM CELL; FOAM CELL; FOOD INTAKE; HEART FAILURE; HEART PROTECTION; HUMAN; IN VITRO STUDY; ISCHEMIC HEART DISEASE; MACROPHAGE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OXIDATION; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; VASODILATATION; VITAMIN METABOLISM;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; FEMALE; FOOD; HUMANS; LIPOPROTEINS, LDL; MALE; MICE; OXIDATION-REDUCTION; VITAMIN E; VITAMINS;

EID: 77952527791     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31819cdc9a     Document Type: Review

References (34)

1. Brigelius-Flohe R, Traber M. Vitamin E: function and metabolism. FASEB J. 1999;13:1145-1155.
2. Dutta A, Dutta S. Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: a review. J Am Coll Nutr. 2003;22:258-268. (Pubitemid 36927760)
3. Brigelius-Flohé R, Kelly FJ, Salonen JT, et al. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr. 2002;76:703-716.
4. Kumar V, Abbas A, Fausto N. Robbins and Cotran Pathologic Basis of Disease, 7th ed. Philadelphia: Elsevier Inc; 2005:516-524.
5. Lusis AJ. Atherosclerosis. Nature. 2000;407:233.
6. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
7. Deveraj S, Li D, Jialal I. The effect of alpha-tocopherol supplementation on monocyte function: decreased lipid oxidation, interleukin-1 beta secretion and monocyte adhesion to endothelium. J Clin Invest. 1996;98:756-763.
8. Jialal I, Deveraj S, Kaul N. The effect of alpha-tocopherol on monocyte proatherogenic activity. J Nutr. 2001;131:389S-394S.
9. van Tits L, Demacker P, de Graaf J, et al. Alpha-tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals. Am J Clin Nutr. 2000;71:458-464.
10. Islam K, Deveraj S, Jialal I. Alpha-tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation. 1998;98:2255-2261.
11. Esterbauer H, Dieber-Rotheneder M, Striegl G, et al. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr. 1991;53(Suppl): 314S-321S.
12. Reaven PD, Khouw A, Beltz WF, et al. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb. 1993;13:590-600.
13. Ferre N, Camps J, Paul A, et al. Effects of high-fat, low-cholesterol diets on hepatic lipid peroxidation and antioxidants in apolipoprotein E-deficient mice. Mol Cell Biochem. 2001;218:165-169.
14. Thomas S, Leichtweis S, Pettersson K, et al. Dietary cosupplementation with vitamin E and coenzyme Q (10) inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol. 2001;21:585-593.
15. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med. 1993;328:1444-1449.
16. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
17. Kushi LH, Folsom AR, Prineas RJ, et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996;334:1156-1162.
18. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
19. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 1997;349:1715-1720.
20. Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000;356:1213-1218.
21. de Gaetano G; Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet. 2001;357:89-95
22. [erratum in Lancet. 2001;357:1134].
23. Hodis HN, Mack WJ, LaBree L, et al. VEAPS Research Group. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation. 2002;106:1453-1459.
24. Lee I-Min, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005;294:56-65.
25. Sesso H, Buring J, Christen W, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008;300:2123-2133.
26. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447-455
27. [erratum in Lancet. 2001;357:642].
28. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-160.
29. Lonn E, Yusuf S, Hoogwerf B, et al. HOPE Study; MICRO-HOPE Study. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care. 2002;25:1919-1927.
30. Heinonen OP, Albanes D. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330:1029-1035.
31. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:1338-1347.
32. Miller E, Pastor-Barriuso R, Dalal D, et al. Meta-alysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.
33. Kris-Etherton P, Lichtenstein A, Howard B, et al. Anti-oxidant vitamin supplements and cardiovascular disease. Circulation. 2004;110:637-641.
34. Lichtenstein A, Appel L, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82-96.